Cyto Pulse Sciences, Inc
Contact
Laboratory Research Systems

More Events...

  • Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers
    See Press Release for
    more information...

More News More Press Releases

 
 
 

NOTICE OF PUBLIC AUCTION AND/OR PRIVATE SALES OF ALL ASSETS OF THE DEBTOR, INCLUDING BUT NOT LIMITED TO INTELLECTUAL PROPERTY, OFFICE FURNITURE, EQUIPMENT, AND COMPUTERS FREE AND CLEAR OF LIENS, ENCUMBRANCES AND OTHER INTERESTS WITH THE CONSENT OF SECURED CREDITOR ICHOR MEDICAL SYSTEMS.

TYPE OF SALE:  Public Auction and/or Private Sales.

PROPERTY TO BE SOLD:  All assets of the Debtor, in any form, including but not limited to: intellectual property, office furniture, equipment, and computers. Visit http://www.hilcoind.com and /or www.hgpauction.com for details and pictures of items.

PRICE:  Highest bid as detailed in the Exclusive Auction Agreement attached as Exhibit A to Trustee’s Application to Employ and Compensate Auctioneer (Docket # 17) and the terms and conditions posted on http://www.hilcoind.com and /or www.hgpauction.com.

SCHEDULED VALUE:  $1,100,872, although the Trustee believes the assets were dramatically undervalued on the Debtor’s schedules.

PLACE AND TIME OF SALEAugust 24, 2010, beginning at 10:00 am, 810 Cromwell Park Drive, Suite T, Glen Burnie, Maryland 21061. Auction will be conducted on location and over the Internet using webcast technology. See http://www.hilcoind.com and /or www.hgpauction.com for details.

More info by clicking here or at the links above.


NOTE:  Cyto Pulse Sciences, Inc. filed for Chapter 7 (liquidation) bankruptcy protection in the United States Bankruptcy Court for the Maryland (Baltimore) on June 29, 2010.  The case number is 10-24689-NVA.  Brian A. Goldman was appointed Interim Trustee on June 30, 2010.  A meeting of creditors is scheduled for August 6, 2010 at 12:00 PM at the Garmatz, Courthouse 101 West Lombard Street, Suite 2625, Baltimore, Maryland 21201.  All assets of the Debtor are going to be liquidated. If you are interested in purchasing assets of the Debtor, or finding out more information, please call:

Evan M. Goldman, Esquire
Counsel to Chapter 7 Trustee
Goldman & Goldman, P.A.
36 South Charles Street, Suite 2401
Baltimore, Maryland 21201
emg@goldmangoldman.com
410-547-1400 x226 Telephone
410-547-8818 Fax

 

Cyto Pulse Sciences, Inc. is a medical device and treatment development company dedicated to advancing quality of life through novel electric field based technologies to produce and deliver new medicine therapeutics (polynucleotides) for:

Cancer treatments (immunotherapy)

Protection against infectious diseases (prophylaxis therapy)

Correcting a genetic defect
(gene therapy)

 

Cyto Pulse Pipeline Cyto Pulse Pipeline Cyto Pulse Pipeline Cyto Pulse Pipeline
 
 
 
Cyto Pulse Sciences  Contact Info
 


 

Commercial and Clinical Technology DNA Vaccine Delivery mAb Discovery Large Volume Transfection Veterinary Oncology Home Company News Science Contact Site Map